fbpx

2024–2025 Annual Report

In this Report

Introduction

In 2025, Hepatitis Queensland proudly celebrates 30 years of service, three decades during which we’ve stood alongside people in Queensland living with, or at risk of, viral hepatitis, and championed education, prevention, testing, treatment and monitoring of liver health. As the state’s peak body for viral hepatitis, we’ve worked to reduce stigma, strengthen connections across health and community sectors, and support better outcomes for individuals, families and communities.

Since our founding in 1995, we have seen remarkable progress: new treatments, expanded testing, growth in peer-led and community-based models, and greater awareness of liver health issues. Yet too many Queenslanders still face barriers to testing, treatment, and care. That’s why our work remains focused on improving access, empowering communities, and strengthening partnerships across health and community services.

This report captures the highlights of our work over the 2024-25 period including innovative programs, expanded outreach services, and new initiatives to reach people where they are. Every step brings us closer to our vision: a Queensland where viral hepatitis is no longer a barrier to health and wellbeing, and where liver health is embraced everywhere.

As we mark 30 years of progress, we remain ambitious. We’re setting our sights on a future where every Queenslander has the opportunity to live free from viral hepatitis and with good liver health.

A message from our Chair and CEO

Lyn Hamill

Chair

Associate Professor Anna Hawkes

CEO

Our Impact in Numbers

0

People tested for hepatitis C in prisons

0

On-demand training participants

0

Online resources accessed

0

Physical resources distributed

0

People tested in community clinics

0

Liver Scans (FibroScans) performed

0

Education participants (live sessions)

0

Grants we awarded

Our Highlights

In 2024–25, Hepatitis Queensland strengthened awareness, expanded services, built new partnerships, and continued to support Queenslanders affected by viral hepatitis. These highlights reflect the collective efforts of our team, partners and lived experience community.

Here’s an overview of what we accomplished this year.

Our Organisation

Hepatitis Queensland is supported by a skilled and dedicated Board that provides strong governance and strategic oversight. We acknowledge the valuable contribution of outgoing Board Chair Dr Jonathan Leitch, who stepped down during this reporting period. Lyn Hamill was appointed as the new Chair, bringing extensive leadership experience and a deep commitment to improving health outcomes for Queenslanders.

Hepatitis Queensland Board 2024–25

  • Chair: Lyn Hamill
  • Deputy Chair: Dr Enoka Gonsalkorala
  • Treasurer: Kaveen Bachoo
  • Board Member: Dr Ciny Clayton
  • Board Member: Rebekah Lamb
  • Board Member: Dr Jacqui Richmond
  • Board Member: Jo Stone
  • Board Member: Dr James Thomas

Our work is powered by a passionate and skilled team committed to eliminating viral hepatitis and improving liver health across Queensland. This year we welcomed new staff and farewelled team members who made valuable contributions during their time with the organisation.

Hepatitis Queensland Staff 2024–25

  • Chief Executive Officer: Associate Professor Anna Hawkes
  • Programs Manager: Rachael Thompson
  • Office & Administration Manager: Jo Coffey
  • Cultural Lead, Aboriginal and Torres Strait Islander People: Nicky Newley-Guivarra
  • Senior Project Officer: Lana Richardson (until March 2025)
  • Senior Communications Officer: Jessie Badger
  • Communications Support Officer: Amy Dunks
  • Community Outreach Nurse: Jeanette Tibbs
  • Project Officer: Steph Beames
  • Project Officer: Mikayla Leslie
  • Project Officer: Alex Morales

Hepatitis Queensland is committed to meaningful reconciliation and strengthening our work with Aboriginal and Torres Strait Islander peoples and communities. During this reporting period, we continued progressing our Innovate Reconciliation Action Plan (RAP) 2.0, focusing on collaboration, cultural learning, and improving access to viral hepatitis information, prevention, and care.

Hepatitis Queensland successfully met all accreditation requirements during this reporting period. This achievement reflects our ongoing commitment to transparent governance, continuous improvement, and delivering safe, high-quality services to the community.

Our organisation continues to be guided by the insights and expertise of our Lived-Living Experience Advisory Network (LEAN). LEAN members, people with lived or living experience of hepatitis B or hepatitis C, play a critical role in shaping our programs, resources, and strategic direction to ensure our work remains relevant, respectful, and impactful.

Our Future

Hepatitis Queensland will continue to build on our positive outcomes this year. Looking ahead, our focus will be on strengthening existing and building new partnerships, expanding hepatitis prevention, testing, treatment, and ongoing care, continuing to support some of our most disadvantaged Queenslanders and communities, and most importantly embedding the voices of people with lived-living experience in everything we do.

Guided by our Innovate Reconciliation Action Plan 2.0, we will deepen our engagement with Aboriginal and/or Torres Strait Islander communities, ensuring culturally safe and collaborative approaches. We will continue working closely with partners across health, social services, and correctional settings to scale successful models such as rapid testing initiatives in Community Correctional Centres and prisons.

We will also broaden our workforce development and community education activities to increase viral hepatitis literacy across Queensland, particularly in regional and remote areas, as well as in culturally and linguistically diverse and Aboriginal and/or Torres Strait Islander communities. As digital tools become increasingly important, we will explore new ways to connect Queenslanders with reliable information and support where appropriate.

With strong governance, a committed workforce, and the ongoing guidance of our Lived-Living Experience Advisory Network, Hepatitis Queensland is well placed to drive meaningful progress towards Queensland and national targets to achieve elimination of hepatitis B and hepatitis C as a public health threat by 2030.

Our Financial Statements

Hepatitis Queensland remains committed to strong governance, accountability, and the responsible management of resources. Our financial performance reflects our focus on sustainability, efficient service delivery, and ensuring that funding is directed where it has the greatest impact for communities across Queensland.

The following audited financial statements provide a transparent overview of our income, expenditure, assets, and liabilities for the reporting period. These statements demonstrate our continued commitment to sound financial stewardship as we work towards eliminating viral hepatitis and improving liver health outcomes statewide.

This website may contain the names and images of Aboriginal and Torres Strait Islander people who have passed on.

CLOSE